國投智能(300188.SZ):擬變更公司名稱、住所及修訂《公司章程》等相關制度
格隆匯5月21日丨國投智能(300188.SZ)公佈,鑑於公司業務覆蓋全國、橫跨多個行業,去除現行名稱中的“廈門”行政區劃,符合公司全國展業情況,亦能助力公司更高效開拓全國市場。公司擬更名為:國投智能信息股份有限公司,同時更新英文名稱及簡稱。公司住所搬遷至廈門火炬高新區軟件園二期前埔東路188號19層,因此公司擬變更住所。
由於公司變更名稱及住所,同時為落實《中國人民共和國公司法》及中國證券監督管理委員會發布的《關於新<公司法>配套制度規則實施相關過渡期安排》《上市公司章程指引》等相關法律法規的要求,公司對《公司章程》《股東會議事規則》《董事會議事規則》等相關制度中相應條款進行修訂。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.